Hypershell raises $50M Series B+ to scale X Series exoskeletons
Evidence notes
- Hypershell raised a $50 million Series B+ co-led by Ant Group and Meituan Dragonball.
- The tranche brought the company's Series B total to about $120 million at a near-$400 million post-money valuation.
- The financing supported global commercialization of Hypershell's X Series exoskeletons.
Company context
Hypershell develops powered wearable exoskeletons for outdoor mobility, hiking, exploration, and field-assistance use cases. Its X Series products use AI-assisted motion response to augment walking, climbing, and load-bearing activity.